We are live on ! Find out more
ALIM icon

Alimera Sciences

Delisted

ALIM was delisted on the 13th of September, 2024.

16 hedge funds and large institutions have $4.3M invested in Alimera Sciences in 2023 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 2

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

2.98% less ownership

Funds ownership: 32.28% → 29.3% (-3%)

20% less funds holding

Funds holding: 20 → 16 (-4)

90% less capital inflows, than outflows

Capital inflows: $62.9K | Capital outflows: $640K

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 4

Holders
16
Holders Change
-4
Holders Change %
-20%
% of All Funds
0.25%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
–
Increased
4
Reduced
2
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

ALIM Hedge Fund Activity: Q1 2023 in Review

16 of the 6,291 institutional investors tracked by Wall St. Rank reported a position in Alimera Sciences (ALIM) for Q1 2023, worth a combined $4.3M — down 30% from $6.13M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of ALIM and 0 opened new positions — a net loss of 4 holders — while 2 trimmed existing stakes and 4 added.

The largest buyer was Millennium Management, adding an estimated $39K. The largest seller was Palo Alto Investors, exiting entirely with an estimated $544K sold.

  • 16 institutional investors held Alimera Sciences (ALIM) as of Q1 2023, down from 20 in Q4 2022.
  • Funds reported $4.3M of Alimera Sciences stock for Q1 2023, down 30% quarter-over-quarter.
  • 0 funds opened new Alimera Sciences positions in Q1 2023 and 4 closed out, a net change of -4 holders.
  • The largest Alimera Sciences buyer in Q1 2023 was Millennium Management, an estimated $39K added.
  • The largest Alimera Sciences seller in Q1 2023 was Palo Alto Investors, an estimated $544K sold.

Based on aggregated 13F filings for Q1 2023.